| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
INVITED REVIEW
1Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany; and 2Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia
Activation of cells by receptor- and nonreceptor-mediated stimuli not only requires a change in the activity of signaling proteins but also requires a reorganization of the topology of the signalosom in the cell. The cell membrane contains distinct domains, rafts that serve the spatial organization of signaling molecules in the cell. Many receptors or stress stimuli transform rafts by the generation of ceramide. These stimuli activate the acid sphingomyelinase and induce a translocation of this enzyme onto the extracellular leaflet of the cell membrane. Surface acid sphingomyelinase generates ceramide that serves to fuse small rafts and to form large ceramide-enriched membrane platforms. These platforms cluster receptor molecules, recruit intracellular signaling molecules to aggregated receptors, and seem to exclude inhibitory signaling factors. Thus ceramide-enriched membrane platforms do not seem to be part of a specific signaling pathway but may facilitate and amplify the specific signaling elicited by the cognate stimulus. This general function may enable these membrane domains to be critically involved in the induction of apoptosis by death receptors and stress stimuli, bacterial and viral infections of mammalian cells, and the regulation of cardiovascular functions.
signal transduction; acid sphingomyelinase; rafts; membrane platforms
P. L. Li, Dept. of Pharmacology and Toxicology, Virginia Commonwealth Univ., Richmond, VA 23298-0613 (e-mail: pli{at}mail1.vcu.edu)
This article has been cited by other articles:
|
|
 |
|
  A. Cogolludo, L. Moreno, G. Frazziano, J. Moral-Sanz, C. Menendez, J. Castaneda, C. Gonzalez, E. Villamor, and F. Perez-Vizcaino Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction Cardiovasc Res, May 1, 2009; 82(2): 296 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Uhlig and E. Gulbins Sphingolipids in the Lungs Am. J. Respir. Crit. Care Med., December 1, 2008; 178(11): 1100 - 1114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jin, F. Yi, F. Zhang, J. L. Poklis, and P.-L. Li Lysosomal Targeting and Trafficking of Acid Sphingomyelinase to Lipid Raft Platforms in Coronary Endothelial Cells Arterioscler. Thromb. Vasc. Biol., November 1, 2008; 28(11): 2056 - 2062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Deng, X. Yin, R. Allan, D. D. Lu, C. W. Maurer, A. Haimovitz-Friedman, Z. Fuks, S. Shaham, and R. Kolesnick Ceramide Biogenesis Is Required for Radiation-Induced Apoptosis in the Germ Line of C. elegans Science, October 3, 2008; 322(5898): 110 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hernandez, M. Shpak, T. T. Duarte, T. L. Mendez, R. A. Maldonado, S. Roychowdhury, M. L. Rodrigues, and S. Das Novel Role of Sphingolipid Synthesis Genes in Regulating Giardial Encystation Infect. Immun., July 1, 2008; 76(7): 2939 - 2949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. von Bismarck, C.-F. Garcia Wistadt, K. Klemm, S. Winoto-Morbach, U. Uhlig, S. Schutze, D. Adam, B. Lachmann, S. Uhlig, and M. F. Krause Improved Pulmonary Function by Acid Sphingomyelinase Inhibition in a Newborn Piglet Lavage Model Am. J. Respir. Crit. Care Med., June 1, 2008; 177(11): 1233 - 1241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Corcoran, Q. He, S. Ponnusamy, B. Ogretmen, Y. Huang, and M. S. Sheikh Neutral Sphingomyelinase-3 Is a DNA Damage and Nongenotoxic Stress-Regulated Gene That Is Deregulated in Human Malignancies Mol. Cancer Res., May 1, 2008; 6(5): 795 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Jin, Y. Zhang, F. Yi, and P.-L. Li Critical Role of Lipid Raft Redox Signaling Platforms in Endostatin-Induced Coronary Endothelial Dysfunction Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 485 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kolak, J. Westerbacka, V. R. Velagapudi, D. Wagsater, L. Yetukuri, J. Makkonen, A. Rissanen, A.-M. Hakkinen, M. Lindell, R. Bergholm, et al. Adipose Tissue Inflammation and Increased Ceramide Content Characterize Subjects With High Liver Fat Content Independent of Obesity Diabetes, August 1, 2007; 56(8): 1960 - 1968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yoshida and R. M. Tuder Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease Physiol Rev, July 1, 2007; 87(3): 1047 - 1082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bonnaud, C. Niaudet, G. Pottier, M.-H. Gaugler, J. Millour, J. Barbet, L. Sabatier, and F. Paris Sphingosine-1-Phosphate Protects Proliferating Endothelial Cells from Ceramide-Induced Apoptosis but not from DNA Damage-Induced Mitotic Death Cancer Res., February 15, 2007; 67(4): 1803 - 1811. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Chen, D. B. Jump, W. J. Esselman, and J. V. Busik Inhibition of Cytokine Signaling in Human Retinal Endothelial Cells through Modification of Caveolae/Lipid Rafts by Docosahexaenoic Acid Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 18 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. B. Persson Where we stand: American Journal of Physiology--Regulatory, Integrative and Comparative Physiology 2006 Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R489 - R490. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
